Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 9 chart positions in 9 markets.
By chart position
- 🇮🇳IN · Medicine#7110K to 30K
- 🇿🇦ZA · Medicine#3910K to 30K
- 🇸🇦SA · Medicine#863K to 10K
- 🇮🇱IL · Medicine#112500 to 3K
- 🇲🇾MY · Medicine#112500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
18K to 62K🎙 Weekly cadence·19 episodes·Last published 10mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
26K to 88K🇮🇳34%🇿🇦34%🇸🇦11%+6 more - Active Followers
Loyal subscribers who consistently listen
7.8K to 26K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Treatment of Axial Spondyloarthritis (including Ankylosing Spondylitis)
Jun 26, 2025
Unknown duration
Ankylosing Spondylitis (Axial Spondyloarthritis) Part 1: Everything other than treatment.
Dec 17, 2024
Unknown duration
Uveitis
Jun 27, 2024
Unknown duration
Still’s Disease
Nov 9, 2023
Unknown duration
Scleroderma Part 2: Management
Apr 26, 2023
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/26/25 | Treatment of Axial Spondyloarthritis (including Ankylosing Spondylitis) | What you need to know to treat axial spondyloarthritis (including Ank Spond). Non-pharmacologic management, specific information on the drugs, how to customize treatment, monitoring and tapering. We’ll also discuss ORAL surveillance briefly at the end of the episode. | — | ||||||
| 12/17/24 | Ankylosing Spondylitis (Axial Spondyloarthritis) Part 1: Everything other than treatment. | What you need to know about Axial Spondyloarthritis (including Ankylosing Spondylitis) for clinical practice and your board exams. In Part 1, we will explore important Background, Epidemiology, Pathophysiology, Clinical Presentation, Work-up, Classification and more! | — | ||||||
| 6/27/24 | Uveitis | What you need to know about uveitis for your clinical practice and rheumatology board exams. This includes what uveitis actually is, how to think about/classify uveitis in your mind (anatomically; infectious vs non-infectious; systemic vs eye-limited), causes of uveitis, the clinical presentation, workup, management and some extra stuff. As always, "Quiz Time’s” are scattered through the episode to check your understanding. | — | ||||||
| 11/9/23 | Still’s Disease | What you need to know about Still’s Disease (formerly Adult Onset Still’s Disease/Systemic JIA) for clinical practice and your board exams. | — | ||||||
| 4/26/23 | Scleroderma Part 2: Management | The fundamentals of what you need for patient encounters and your boards. In this episode we’ll exclusively discuss the management of systemic sclerosis. This includes treatment of the skin, esophageal disease, interstitial lung disease, pulmonary arterial hypertension and scleroderma renal crisis. | — | ||||||
| 4/19/23 | Scleroderma Part 1: Clinical Presentation And Workup | The fundamentals of what you need for your patient encounters and board exams. In this episode we’ll discuss a little epidemiology and pathophys, but focus heavily on the clinical presentation and workup. Part 2 will come out soon and focus on the management of systemic sclerosis. | — | ||||||
| 3/7/23 | Gout Part 2: Treatment | How to manage gout! During the flare, urate lowering therapy, anti-inflammatory prophylaxis, dietary recommendations, managing gout with chronic kidney disease and lots more. | — | ||||||
| 2/27/23 | Gout Part 1: Background, Presentation and Diagnosis | We’ll focus on everything you need to know, short of management. This means pathophys, epidemiology, clinical presentation, workup and diagnosis. | — | ||||||
| 12/14/22 | Antiphospholipid Syndrome | What you need to know about the Antiphospholipid Syndrome for your boards and clinical practice. We’ll discuss a little pathophysiology and epidemiology, but mostly focus on the clinical presentation, workup and management, as well as Catastrophic APS (CAPS). | — | ||||||
| 11/8/22 | Rheumatoid Arthritis Management: Part 2 | Episode #2 of a 2-part series. Part 2 is all about how to handle specific scenarios and clinical pearls. We delve into methotrexate optimization, what to do when therapy fails, the safety of JAK inhibitors, pregnancy management in RA, DMARDs and malignancy, palindromic rheumatism, perioperative management, biosimilars and more. | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/27/22 | Rheumatoid Arthritis Management: Part 1 | Episode #1 of a 2-part series. Part 1 will provide a rundown of the guidelines and the most important drugs in the treatment of rheumatoid arthritis. Part 2 will be published shortly after. | — | ||||||
| 10/8/21 | PMR and GCA Part 2: Management | What you need to know for your boards on how to manage Polymyalgia Rheumatica and Giant Cell Arteritis. | — | ||||||
| 10/8/21 | PMR and GCA Part 1: Background, presentation and diagnosis | What you need to know for your boards on Polymyalgia Rheumatica and Giant Cell Arteritis: A little epidemiology and pathophysiology, with a particular focus on the clinical presentation and workup (including imaging). | — | ||||||
| 6/24/21 | Psoriatic Arthritis | What you need to know for your rheumatology boards (and some!). The treatment landscape of PsA is rapidly evolving, so I placed special emphasis on pharmacologic management in this episode. We also discuss 3 challenging scenarios in the last 9 minutes. | — | ||||||
| 4/14/21 | Lupus Nephritis | What you need to know for your rheumatology boards (and some) is summarized in the first 55 minutes. There are an additional 20 minutes of high yield material at the end, including lupus nephritis in pregnancy and renal transplant, which I think are important for the exam and clinical practice. | — | ||||||
| 3/4/21 | ANCA Vasculitis | What you need to know for your rheumatology boards: Epidemiology, pathophysiology, presentation, work-up, management, prognosis and of course, quiz time! EGPA gets its own segment in the last 15 minutes of this episode. | — | ||||||
| 11/25/20 | IgG4-Related Disease | What you need to know for your boards: Epidemiology, mechanisms, presentation, work-up, management, prognosis and of course, quiz time! Special thanks to Dr. John Stone for his ongoing help with my IgG4-related questions over the years. | — | ||||||
| 9/8/20 | Myositis | What you need to know for your boards: A little epidemiology and etiology, but a particular focus on the workup (including autoantibody profile) and management of autoimmune myositis. | — | ||||||
| 7/22/20 | Osteoporosis | What you need to know for your boards: The epidemiology, presentation, and a particular focus on diagnosis, work-up and management of osteoporosis. | — | ||||||
Showing 19 of 19
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
9 placements across 9 markets.
Chart Positions
9 placements across 9 markets.